MWR
ATRS

McAdams Wright Ragen’s Antares Pharma, Inc. ATRS Stock Holding History

McAdams Wright Ragen’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$559K Hold
305,666
– – 0.03% 248
2014
Q2 		$816K Buy
305,666
+41,666
+16% +$125K 0.05% 208
2014
Q1 		$924K Buy
264,000
+5,000
+2% +$22.2K 0.06% 189
2013
Q4 		$1.16M Buy
259,000
+14,562
+6% +$59.3K 0.08% 172
2013
Q3 		$992K Buy
244,438
+10,438
+4% +$45.6K 0.08% 166
2013
Q2 		$973K Buy
+234,000
New +$904K 0.08% 173

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

McAdams Wright Ragen's ATRS Position: Q3 2014 in Review

McAdams Wright Ragen held its Antares Pharma, Inc. (ATRS) position steady in Q3 2014 at 305,666 shares worth $559K. The position accounts for 0.03% of the portfolio, ranked #248.

McAdams Wright Ragen first reported a position in ATRS in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.16M in Q4 2013. 82 funds tracked by Wall St. Rank hold ATRS as of Q3 2014.

  • McAdams Wright Ragen held 305,666 shares of Antares Pharma, Inc. worth $559K as of Q3 2014.
  • McAdams Wright Ragen left its Antares Pharma, Inc. share count unchanged in Q3 2014.
  • Antares Pharma, Inc. made up 0.03% of McAdams Wright Ragen's portfolio in Q3 2014, its #248 holding.
  • McAdams Wright Ragen first reported a position in Antares Pharma, Inc. in Q2 2013 and has held it in 6 quarters since.
  • McAdams Wright Ragen's Antares Pharma, Inc. position peaked at $1.16M in Q4 2013.
  • 82 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.